CD274 and neoplasm: Indeed, compared to ICI monotherapy, we identified higher anti-MOC1 associated IgG titers after armed and unarmed virus treatment (in both anti-PD-1 and anti-PD-L1 refractory tumors), but the highest anti-tumor antibody values identified were in the combination treatment group (Figures 5A, E).